España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Nevro
NVRO
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.79
0.20
5.57%
At close: -
$3.79
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
Nevro (NVRO) Forecast
News
Earnings
Nevro (NVRO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Nevro (NYSE:NVRO) Stock
Nevro Stock (NYSE: NVRO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Where Nevro Stands With Analysts
Benzinga Insights
Truist Securities Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Wednesday, December 11, 2024
Citigroup Maintains Neutral on Nevro, Lowers ...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Nevro, ...
Benzinga Newsdesk
Monday, December 09, 2024
Canaccord Genuity Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Tuesday, December 03, 2024
Wells Fargo Reinstates Equal-Weight on Nevro,...
Benzinga Newsdesk
Monday, December 02, 2024
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Vandana Singh
What Analysts Are Saying About Nevro Stock
Benzinga Insights
Morgan Stanley Downgrades Nevro to Underweigh...
Benzinga Newsdesk
Tuesday, November 12, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why Medical Device Firm Nevro Stock Is Trading Higher On Tuesday
Vandana Singh
Canaccord Genuity Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Peeling Back The Layers: Exploring Nevro Through Analyst Insights
Benzinga Insights
JMP Securities Reiterates Market Perform on N...
Benzinga Newsdesk
RBC Capital Reiterates Sector Perform on Nevr...
Benzinga Newsdesk
Nevro Corp shares are trading higher after Ba...
Benzinga Newsdesk
Nevro Has Received CE Mark Certification In E...
Benzinga Newsdesk
Baird Maintains Neutral on Nevro, Raises Pric...
Benzinga Newsdesk
Piper Sandler Maintains Underweight on Nevro,...
Benzinga Newsdesk
Monday, November 11, 2024
Nevro Corp shares are trading higher after th...
Benzinga Newsdesk
Nevro Sees FY24 Revenue $400M-$405M Vs $402.5...
Benzinga Newsdesk
Nevro Q3 EPS $(0.41) Beats $(0.76) Estimate, ...
Benzinga Newsdesk
Earnings Scheduled For November 11, 2024
Benzinga Insights
Friday, November 08, 2024
A Look Ahead: Nevro's Earnings Forecast
Benzinga Insights
Tuesday, October 29, 2024
Nevro Corp Announced The Publication Of New D...
Benzinga Newsdesk
Tuesday, October 01, 2024
Breaking Down Nevro: 10 Analysts Share Their Views
Benzinga Insights
Citigroup Maintains Neutral on Nevro, Lowers ...
Benzinga Newsdesk
Tuesday, September 24, 2024
Nevro Launches AI-Driven HFX AdaptivAI, The F...
Benzinga Newsdesk
Friday, August 09, 2024
Citigroup Upgrades Nevro to Neutral, Announce...
Benzinga Newsdesk
Thursday, August 08, 2024
Wolfe Research Upgrades Nevro to Peer Perform
Benzinga Newsdesk
Assessing Nevro: Insights From 9 Financial Analysts
Benzinga Insights
Truist Securities Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Wednesday, August 07, 2024
JMP Securities Downgrades Nevro to Market Per...
Benzinga Newsdesk
Evaluating Nevro: Insights From 8 Financial Analysts
Benzinga Insights
RBC Capital Maintains Sector Perform on Nevro...
Benzinga Newsdesk
Baird Maintains Neutral on Nevro, Lowers Pric...
Benzinga Newsdesk
Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Wells Fargo Downgrades Nevro to Underweight, ...
Benzinga Newsdesk
JP Morgan Downgrades Nevro to Underweight
Benzinga Newsdesk
Nevro shares are trading lower after the comp...
Benzinga Newsdesk
Piper Sandler Maintains Underweight on Nevro,...
Benzinga Newsdesk
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, August 06, 2024
Nevro Sees Q3 2024 Worldwide Revenue $92M-$94...
Benzinga Newsdesk
Nevro Sees FY24 Adj. EBITDA $(20M)-$(18M)
Benzinga Newsdesk
Nevro shares are trading lower after the comp...
Benzinga Newsdesk
Nevro Q2 2024 GAAP EPS $(0.53) Beats $(0.68) ...
Benzinga Newsdesk
Tuesday, July 16, 2024
Truist Securities Maintains Hold on Nevro, Lo...
Benzinga Newsdesk
Monday, July 15, 2024
Beyond The Numbers: 6 Analysts Discuss Nevro Stock
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Nevr...
Benzinga Newsdesk
Thursday, July 11, 2024
Citigroup Maintains Sell on Nevro, Lowers Pri...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch